logo-loader

Genetic Technologies tops ASX Most Traded ahead of Nasdaq trading

Published: 01:37 10 Jan 2018 GMT

1515548630_old-lady-in-hospital-100118
The ASX most active

Genetic Technologies Ltd (ASX:GTG; Nasdaq:GENE) is the most active stock intra-day with over 113 million shares changing hands, although its value has eased 10.5% to $0.017.

The company has regained compliance with Nasdaq Marketplace following a deficiency notice in mid-2017.

Genetic Technologies is a molecular diagnostics company that offers cancer predictive testing and assessment tools to help physicians proactively manage patient health.

The company’s lead product, BREVAGenplus®, is a clinically validated risk assessment test for non-hereditary breast cancer and is first in its class.

Adding interest and following a strategic review, the company remains in active discussions with multiple parties regarding a potential transaction.

Further details will be closely monitored by investors.

Company Name Code Last Change Volume
Genetic Technologies Ltd GTG $0.017 -10.53% 113,744,014
Pancontinental Oil & Gas NL PCL $0.005 0% 95,747,144
Queensland Bauxite Ltd QBL $0.069 -8% 71,822,947
Bard1 Life Sciences Ltd BD1 $0.016 33.33% 64,333,658
Atlas Iron Ltd AGO $0.032 -3.03% 64,299,962
Ardiden Ltd ADV $0.023 15% 61,450,080
Serpentine Technologies Ltd S3R $0.017 21.43% 49,188,225
Fatfish Internet Group Ltd FFG $0.100 21.95% 36,935,922
Kairos Minerals Ltd KAI $0.055 14.58% 32,602,587
Lepidico Ltd LPD $0.067 6.35% 27,529,056

 

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

29 minutes ago